Patents by Inventor Paul Rillema

Paul Rillema has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of metabolic dysfunctions using fluorescence emission from serum
    Patent number: 6813009
    Abstract: Serum emission can be used as the first test to detect metabolic disorders in mammals. When changes in emission of the serum from patients with different pathological conditions were characterized, a difference was seen for patients with diseases such as cancer, thyroid disorder, arthritis, diabetes, coronary artery disease (CAD), hypertension, CFS (chronic fatigue syndrome), and fibromyalgia. The level of emission was enhanced or diminished and correlated with the level of energy metabolism and the level of metabolic rate. The method can also be used for risk assessment, to identify whether a treatment is working or to follow the course of a treatment, and to identify changes in energy levels due to stress, etc.
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: November 2, 2004
    Assignee: The Center for the Improvement of Human Functioning, International, Inc.
    Inventors: Hugh D. Riordan, Paul Rillema, Nina Mikarova
  • Detection of metabolic dysfunctions using fluorescence emission from serum
    Publication number: 20030137649
    Abstract: Serum emission can be used as the first test to detect metabolic disorders in mammals. When changes in emission of the serum from patients with different pathological conditions were characterized, a difference was seen for patients with diseases such as cancer, thyroid disorder, arthritis, diabetes, coronary artery disease (CAD), hypertension, CFS (chronic fatigue syndrome), and fibromyalgia. The level of emission was enhanced or diminished and correlated with the level of energy metabolism and the level of metabolic rate. The method can also be used for risk assessment, to identify whether a treatment is working or to follow the course of a treatment, and to identify changes in energy levels due to stress, etc.
    Type: Application
    Filed: September 18, 2001
    Publication date: July 24, 2003
    Inventors: Hugh D. Riordan, Paul Rillema, Nina Mikarova